Oral, rat: LD50 = 4280 mg/kg. Symptoms of overdose include mild hypercalcemia (constipation; loss of appetite; nausea and vomiting), and severe hypercalcemia (confusion; full or partial loss of consciousness; incoherent speech).
The chemical compound calcium acetate is the calcium salt of acetic acid. It has been commonly referred to as the acetate of lime. The anhydrous form is very hygroscopic, therefore the monohydrate is the common form.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Moxifloxacin | Calcium acetate can cause a decrease in the absorption of Moxifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Grepafloxacin | Calcium acetate can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enoxacin | Calcium acetate can cause a decrease in the absorption of Enoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pefloxacin | Calcium acetate can cause a decrease in the absorption of Pefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ciprofloxacin | Calcium acetate can cause a decrease in the absorption of Ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Trovafloxacin | Calcium acetate can cause a decrease in the absorption of Trovafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nalidixic acid | Calcium acetate can cause a decrease in the absorption of Nalidixic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rosoxacin | Calcium acetate can cause a decrease in the absorption of Rosoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Cinoxacin | Calcium acetate can cause a decrease in the absorption of Cinoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Lomefloxacin | Calcium acetate can cause a decrease in the absorption of Lomefloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gatifloxacin | Calcium acetate can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Norfloxacin | Calcium acetate can cause a decrease in the absorption of Norfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Levofloxacin | Calcium acetate can cause a decrease in the absorption of Levofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Gemifloxacin | Calcium acetate can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ofloxacin | Calcium acetate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sparfloxacin | Calcium acetate can cause a decrease in the absorption of Sparfloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Temafloxacin | Calcium acetate can cause a decrease in the absorption of Temafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Fleroxacin | Calcium acetate can cause a decrease in the absorption of Fleroxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Technetium Tc-99m ciprofloxacin | Calcium acetate can cause a decrease in the absorption of Technetium Tc-99m ciprofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Garenoxacin | Calcium acetate can cause a decrease in the absorption of Garenoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Nemonoxacin | Calcium acetate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Flumequine | Calcium acetate can cause a decrease in the absorption of Flumequine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Enrofloxacin | Calcium acetate can cause a decrease in the absorption of Enrofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Orbifloxacin | Calcium acetate can cause a decrease in the absorption of Orbifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sarafloxacin | Calcium acetate can cause a decrease in the absorption of Sarafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Difloxacin | Calcium acetate can cause a decrease in the absorption of Difloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pazufloxacin | Calcium acetate can cause a decrease in the absorption of Pazufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Prulifloxacin | Calcium acetate can cause a decrease in the absorption of Prulifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Delafloxacin | Calcium acetate can cause a decrease in the absorption of Delafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Sitafloxacin | Calcium acetate can cause a decrease in the absorption of Sitafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Oxolinic acid | Calcium acetate can cause a decrease in the absorption of Oxolinic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Rufloxacin | Calcium acetate can cause a decrease in the absorption of Rufloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Pipemidic acid | Calcium acetate can cause a decrease in the absorption of Pipemidic acid resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Ceftriaxone | The risk or severity of adverse effects can be increased when Calcium acetate is combined with Ceftriaxone. |
| Deferiprone | The serum concentration of Deferiprone can be decreased when it is combined with Calcium acetate. |
| Dobutamine | The therapeutic efficacy of Dobutamine can be decreased when used in combination with Calcium acetate. |
| Dolutegravir | The serum concentration of Dolutegravir can be decreased when it is combined with Calcium acetate. |
| Eltrombopag | The serum concentration of Eltrombopag can be decreased when it is combined with Calcium acetate. |
| Estramustine | Calcium acetate can cause a decrease in the absorption of Estramustine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcium glucoheptonate | The risk or severity of adverse effects can be increased when Calcium glucoheptonate is combined with Calcium acetate. |
| Calcium chloride | The risk or severity of adverse effects can be increased when Calcium chloride is combined with Calcium acetate. |
| Calcium | The risk or severity of adverse effects can be increased when Calcium is combined with Calcium acetate. |
| Calcium carbonate | The risk or severity of adverse effects can be increased when Calcium carbonate is combined with Calcium acetate. |
| Calcium citrate | The risk or severity of adverse effects can be increased when Calcium citrate is combined with Calcium acetate. |
| Calcium gluconate | The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Calcium acetate. |
| Calcium Phosphate | The risk or severity of adverse effects can be increased when Calcium Phosphate is combined with Calcium acetate. |
| Calcium glubionate anhydrous | The risk or severity of adverse effects can be increased when Calcium glubionate anhydrous is combined with Calcium acetate. |
| Calcium lactate | The risk or severity of adverse effects can be increased when Calcium lactate is combined with Calcium acetate. |
| Calcium lactate gluconate | The risk or severity of adverse effects can be increased when Calcium lactate gluconate is combined with Calcium acetate. |
| Calcium pangamate | The risk or severity of adverse effects can be increased when Calcium pangamate is combined with Calcium acetate. |
| Calcium levulinate | The risk or severity of adverse effects can be increased when Calcium levulinate is combined with Calcium acetate. |
| Calcium cation | The risk or severity of adverse effects can be increased when Calcium cation is combined with Calcium acetate. |
| Calcium polycarbophil | The risk or severity of adverse effects can be increased when Calcium polycarbophil is combined with Calcium acetate. |
| Digoxin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Digoxin. |
| Acetyldigitoxin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigitoxin. |
| Deslanoside | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Deslanoside. |
| Ouabain | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Ouabain. |
| Digitoxin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Digitoxin. |
| Oleandrin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Oleandrin. |
| Cymarin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Cymarin. |
| Proscillaridin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Proscillaridin. |
| Metildigoxin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Metildigoxin. |
| Lanatoside C | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Lanatoside C. |
| Gitoformate | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Gitoformate. |
| Acetyldigoxin | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Acetyldigoxin. |
| Peruvoside | Calcium acetate may increase the arrhythmogenic and cardiotoxic activities of Peruvoside. |
| Strontium ranelate | The serum concentration of Strontium ranelate can be decreased when it is combined with Calcium acetate. |
| Doxycycline | The serum concentration of Doxycycline can be decreased when it is combined with Calcium acetate. |
| Lymecycline | The serum concentration of Lymecycline can be decreased when it is combined with Calcium acetate. |
| Clomocycline | The serum concentration of Clomocycline can be decreased when it is combined with Calcium acetate. |
| Oxytetracycline | The serum concentration of Oxytetracycline can be decreased when it is combined with Calcium acetate. |
| Demeclocycline | The serum concentration of Demeclocycline can be decreased when it is combined with Calcium acetate. |
| Tetracycline | The serum concentration of Tetracycline can be decreased when it is combined with Calcium acetate. |
| Metacycline | The serum concentration of Metacycline can be decreased when it is combined with Calcium acetate. |
| Minocycline | The serum concentration of Minocycline can be decreased when it is combined with Calcium acetate. |
| Sarecycline | The serum concentration of Sarecycline can be decreased when it is combined with Calcium acetate. |
| Omadacycline | The serum concentration of Omadacycline can be decreased when it is combined with Calcium acetate. |
| Penimepicycline | The serum concentration of Penimepicycline can be decreased when it is combined with Calcium acetate. |
| Methyclothiazide | Methyclothiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Chlorthalidone | Chlorthalidone may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Bendroflumethiazide | Bendroflumethiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Metolazone | Metolazone may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Benzthiazide | Benzthiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Hydroflumethiazide | Hydroflumethiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Indapamide | Indapamide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Chlorothiazide | Chlorothiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Hydrochlorothiazide | Hydrochlorothiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Trichlormethiazide | Trichlormethiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Polythiazide | Polythiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Quinethazone | Quinethazone may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Cyclopenthiazide | Cyclopenthiazide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Epitizide | Epitizide may decrease the excretion rate of Calcium acetate which could result in a higher serum level. |
| Triethylenetetramine | Calcium acetate can cause a decrease in the absorption of Triethylenetetramine resulting in a reduced serum concentration and potentially a decrease in efficacy. |
| Calcitriol | The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcium acetate. |
| Calcifediol | The risk or severity of adverse effects can be increased when Calcifediol is combined with Calcium acetate. |
| Ergocalciferol | The risk or severity of adverse effects can be increased when Ergocalciferol is combined with Calcium acetate. |
| Cholecalciferol | The risk or severity of adverse effects can be increased when Cholecalciferol is combined with Calcium acetate. |
| Paricalcitol | The risk or severity of adverse effects can be increased when Paricalcitol is combined with Calcium acetate. |
| Dihydrotachysterol | The risk or severity of adverse effects can be increased when Dihydrotachysterol is combined with Calcium acetate. |
| Alfacalcidol | The risk or severity of adverse effects can be increased when Alfacalcidol is combined with Calcium acetate. |